NCT04814667View on ClinicalTrials.gov

A Retro-/Prospective, Non-interventional, Cohort Study in Adult Patients With Locally Advanced or Metastatic Tumors With a Neurotrophic Tyrosine Receptor Kinase (NTRK) Gene Fusion, Treated With Larotrectinib

CompletedOBSERVATIONAL
Enrollment

26

Participants

Timeline

Start Date

February 23, 2021

Primary Completion Date

September 15, 2024

Study Completion Date

September 15, 2024

Conditions
Solid Tumor, AdultLocally Advanced Solid TumorMetastatic Cancer
Trial Locations (4)

Unknown

CHU Amiens, Amiens

Centre Georges Francois Leclerc, Dijon

Centre Leon Berard, Lyon

Chi Elbeuf Louviers, Saint-Aubin-lès-Elbeuf

Sponsors

Collaborators (1)

Bayer
All Listed Sponsors
collaborator

Bayer

INDUSTRY

lead

Centre Leon Berard

OTHER

NCT04814667 - A Retro-/Prospective, Non-interventional, Cohort Study in Adult Patients With Locally Advanced or Metastatic Tumors With a Neurotrophic Tyrosine Receptor Kinase (NTRK) Gene Fusion, Treated With Larotrectinib | Biotech Hunter | Biotech Hunter